Clinical trial
Irbesartan In Hypertensive Diabetic Patients
NCT00362258 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Irbesartan In Hypertensive Diabetic Patients
- Lead sponsor
- Sanofi
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- February 28, 2006
- Completion date
- September 30, 2008
- Enrollment
- 797 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.